Valeant Pharmaceuticals International said on late Wednesday that it had got 2 federal subpoenas related to its pricing, distribution and patient support practices.

It has been reported that US Food and Drug Administration (FDA) is asking companies, which manufacture testosterone products, for conducting a large clinical trial in order to find out t benefits and

It has been reported that healthcare plans provider Anthem is offering several different levels of free identity theft protection to its present and former customers.

On Thursday, Quebec-based Valeant Pharmaceuticals International Inc. announced that it has entered into a stalking-horse agreement with Dendreon Corp.